Abstract:Sporadic studies in antimicrobial therapy have evaluated the effects of infusion rates on therapeutic and economic outcomes, and new findings may challenge the regular infusion regimen.Focusing on studies comparing the outcomes of different infusion regimens, the relevant literature was identified by searching PubMed, Web of Science, and Scopus from January 1, 2013 to March 1, 2018. Papers were finally chosen using a PRISMA flowchart.Antimicrobials with the superiority of prolonged infusion to standard infusion in terms of efficacy and safety include meropenem, doripenem, imipenem, cefepime, ceftazidime, piperacillin/tazobactam, linezolid, and vancomycin. The strategy of concomitantly reducing total daily dose and prolonging infusion time may cause treatment failure (eg, imipenem). Extended infusion of piperacillin/tazobactam has pharmacoeconomic advantage over standard infusion. Prolonged infusion of voriconazole is inferior to standard infusion because of lower efficacy caused by pharmacokinetic changes. Comparable outcomes following standard infusion and continuous infusion were observed with norvancomycin and nafcillin. Factors determining whether prolonged infusion has a benefit over standard infusion include MIC of bacterial pathogens, bacterial density, diagnosis, disease severity, total daily dose, and renal function.To maximally preserve the effectiveness of current antimicrobials, effective interventions should be implemented to enhance the application of optimal infusion strategies. For reducing nephrotoxicity, prolonged infusion of meropenem is better than conventional infusion in neonates with Gram-negative late-onset sepsis, and continuous infusion of vancomycin is superior to intermittent infusion. For increasing efficacy, prolonged or continuous infusion of time-dependent antimicrobials (eg, meropenem, doripenem, imipenem, cefepime, ceftazidime, piperacillin/tazobactam, linezolid, and vancomycin) is an optimal choice. Nevertheless, such advantages may only be demonstrated in special clinical circumstances and special populations (eg, patients with a sequential organ failure assessment (SOFA) score≥9, respiratory tract infections, urinary or intra-abdominal infections, or infections caused by less susceptible pathogens would benefit from prolonged infusion of piperacillin/tazobactam).

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Extended or Continuous Infusion of Carbapenems in Children with Severe Infections: A Systematic Review and Narrative Synthesis

Optimal Infusion Rate in Antimicrobial Therapy: Explosion of Evidence in the Last Five Years

A Retrospective Analysis of Intravenous Push versus Extended Infusion Meropenem in Critically Ill Patients

Clinical Evaluation of Meropenem in Preterm Neonates for Severe Infections

Efficacy and Safety of Modified Infusion versus Traditional Infusion of Meropenem in the Treatment of Se-vere Infectious:a Meta-analysis

The OBTAINS Study: A Nationwide Cross-Sectional Survey on the Implementation of Extended or Continuous Infusion of Β-Lactams and Vancomycin among Neonatal Sepsis Patients in China

Clinical Evaluation of Extending Administration Time of Meropenem in Treatment of Bacterial Infections in Surgical Intensive Care Unit

Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous Versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study

Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study

Comparison of effect of different infusion of meropenem for patients with sepsis in ICU

Extended Infusion β-Lactams for the Treatment of Gram-Negative Bacteremia in Children

Extended Infusion of Beta-Lactams and Glycopeptides: A New Era in Pediatric Care? A Systematic Review and Meta-Analysis

Prolonged Beta-Lactam Infusions in Children: A Systematic Review and Meta-Analysis

Efficacy and safety of extended or continuous intravenous infusion of carbapenemes against severe infection: a systematic review

Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study

Early and Late Onset Neonatal Sepsis: Epidemiology and Effectiveness of Empirical Antibacterial Therapy in a III Level Neonatal Intensive Care Unit

Reappraisal of the Optimal Dose of Meropenem in Critically Ill Infants and Children: a Developmental Pharmacokinetic-Pharmacodynamic Analysis

Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials